Recent applications of quantum dots in optical and electrochemical aptasensing detection of Lysozyme

Research Progress of Drug Delivery Systems Targeting the Kidneys

Chronic kidney disease (CKD) affects more than 10% of the global population, and its incidence is increasing, partially due to an increase in the prevalence of disease risk factors. Acute kidney injury (AKI) is an independent risk factor for CKD and end-stage renal disease (ESRD). The pathogenic mechanisms of CKD provide several potential targets for its treatment. However, due to off-target effects, conventional drugs for CKD typically require high doses to achieve adequate therapeutic effects, leading to long-term organ toxicity. Therefore, ideal treatments that completely cure the different types of kidney disease are rarely available. Several approaches for the drug targeting of the kidneys have been explored in drug delivery system research. Nanotechnology-based drug delivery systems have multiple merits, including good biocompatibility, suitable degradability, the ability to target lesion sites, and fewer non-specific systemic effects. In this review, the development, potential, and limitations of low-molecular-weight protein-lysozymes, polymer nanomaterials, and lipid-based nanocarriers as drug delivery platforms for treating AKI and CKD are summarized.

Turn-off enzyme activity of histidine-rich peptides for the detection of lysozyme

An assay that integrates histidine-rich peptides (HisRPs) with high-affinity aptamers was developed enabling the specific and sensitive determination of the target lysozyme. The enzyme-like activity of HisRP is inhibited by its interaction with a target recognized by an aptamer. In the presence of the target, lysozyme molecules progressively assemble on the surface of HisRP in a concentration-dependent manner, resulting in the gradual suppression of enzyme-like activity. This inhibition of HisRP's enzyme-like activity can be visually observed through color changes in the reaction product or quantified using UV-visible absorption spectroscopy. Under optimal conditions, the proposed colorimetric assay for lysozyme had a detection limit as low as 1 nM and exhibited excellent selectivity against other nonspecific interferents. Furthermore, subsequent research validated the practical applicability of the developed colorimetric approach to saliva samples, indicating that the assay holds significant potential for the detection of lysozymes in samples derived from humans.

A Dual-Mode Detection Sensor Based on Nitrogen-Doped Carbon Dots for Visual Detection of Fe(III) and Ascorbic Acid via a Smartphone

Accurately and promptly detecting Fe3+ and ascorbic acid (AA) is a crucial objective. In this study, nitrogen-doped carbon dots (N-CDs) were synthesized using a one-step hydrothermal synthesis method with 6,9-diamino-2-ethoxyacridine lactate as the precursor. The introduction of Fe3+ and AA resulted in both fluorescence (FL) quenching and enhancement of the synthesized N-CDs. The fluorescent response of the N-CDs probe to Fe3+ was observed in the concentration range of 5-20 µM and 25-50 µM, with a limit of detection (LOD) of 290 nM. Remarkably, the fluorescence of the N-CDs was recovered upon the addition of AA to the N-CDs-Fe3+ system. Using the "off-on" fluorescent N-CDs probe, a linear range of 40-90 µM was achieved with an LOD of 0.69 µM. Additionally, the feasibility of employing a smartphone equipped with an RGB Color Picker was demonstrated for the analysis of Fe3+ and AA concentrations, providing a novel visual detection method. Furthermore, the application of N-CDs in solution demonstrated considerable potential for visually detecting Fe3+ and AA. The proposed dual-mode detection sensor was found to be simple, efficient, and stable, enabling the successful determination of Fe3+ and AA in practical samples with satisfactory results.

Recent Developments in the Design and Fabrication of Electrochemical Biosensors Using Functional Materials and Molecules

Electrochemical biosensors are superior technologies that are used to detect or sense biologically and environmentally significant analytes in a laboratory environment, or even in the form of portable handheld or wearable electronics. Recently, imprinted and implantable biosensors are emerging as point-of-care devices, which monitor the target analytes in a continuous environment and alert the intended users to anomalies. The stability and performance of the developed biosensor depend on the nature and properties of the electrode material or the platform on which the biosensor is constructed. Therefore, the biosensor platform plays an integral role in the effectiveness of the developed biosensor. Enormous effort has been dedicated to the rational design of the electrode material and to fabrication strategies for improving the performance of developed biosensors. Every year, in the search for multifarious electrode materials, thousands of new biosensor platforms are reported. Moreover, in order to construct an effectual biosensor, the researcher should familiarize themself with the sensible strategies behind electrode fabrication. Thus, we intend to shed light on various strategies and methodologies utilized in the design and fabrication of electrochemical biosensors that facilitate sensitive and selective detection of significant analytes. Furthermore, this review highlights the advantages of various electrode materials and the correlation between immobilized biomolecules and modified surfaces.